NDC11 66215081410
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 66215-0814-10 | 66215-0814 |
| 66215-814-10 | 66215-814 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OPSYNVI | MACITENTAN AND TADALAFIL | Actelion Pharmaceuticals US, Inc. | 6945b183-18d3-40de-afd1-c88e33cc1a63 | 2025-04-11 | Boxed warning, Warnings, Adverse reactions | 66215-814-10 66215-814 66215081410 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.